nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP3A4—Thiotepa—sarcoma	0.0901	0.191	CbGbCtD
Trimipramine—ABCB1—Dactinomycin—sarcoma	0.0723	0.153	CbGbCtD
Trimipramine—ABCB1—Mitoxantrone—sarcoma	0.0647	0.137	CbGbCtD
Trimipramine—ABCB1—Vincristine—sarcoma	0.0445	0.0941	CbGbCtD
Trimipramine—HTR1D—meninx—sarcoma	0.0417	0.251	CbGeAlD
Trimipramine—ABCB1—Etoposide—sarcoma	0.0408	0.0863	CbGbCtD
Trimipramine—CYP3A4—Mitoxantrone—sarcoma	0.0387	0.082	CbGbCtD
Trimipramine—HTR1D—dura mater—sarcoma	0.0384	0.231	CbGeAlD
Trimipramine—ABCB1—Doxorubicin—sarcoma	0.0278	0.0588	CbGbCtD
Trimipramine—CYP3A4—Vincristine—sarcoma	0.0267	0.0564	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—sarcoma	0.0262	0.0554	CbGbCtD
Trimipramine—CYP3A4—Etoposide—sarcoma	0.0244	0.0517	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—sarcoma	0.0167	0.0352	CbGbCtD
Trimipramine—HTR2A—pulmonary artery—sarcoma	0.00814	0.0491	CbGeAlD
Trimipramine—HTR2A—hindlimb—sarcoma	0.00492	0.0297	CbGeAlD
Trimipramine—HTR2A—appendage—sarcoma	0.00422	0.0255	CbGeAlD
Trimipramine—HTR3A—hematopoietic system—sarcoma	0.0031	0.0187	CbGeAlD
Trimipramine—SLC6A3—hematopoietic system—sarcoma	0.00258	0.0156	CbGeAlD
Trimipramine—HTR2A—endothelium—sarcoma	0.00255	0.0154	CbGeAlD
Trimipramine—CYP2C9—mammary gland—sarcoma	0.0025	0.015	CbGeAlD
Trimipramine—HTR1D—connective tissue—sarcoma	0.00243	0.0146	CbGeAlD
Trimipramine—SLC6A4—hematopoietic system—sarcoma	0.00237	0.0143	CbGeAlD
Trimipramine—HTR1A—hematopoietic system—sarcoma	0.0021	0.0127	CbGeAlD
Trimipramine—CYP2C19—hematopoietic system—sarcoma	0.00196	0.0118	CbGeAlD
Trimipramine—ADRA1A—hematopoietic system—sarcoma	0.00194	0.0117	CbGeAlD
Trimipramine—HRH1—myometrium—sarcoma	0.00175	0.0105	CbGeAlD
Trimipramine—ADRA2A—myometrium—sarcoma	0.00172	0.0103	CbGeAlD
Trimipramine—Coordination abnormal—Epirubicin—sarcoma	0.0016	0.00444	CcSEcCtD
Trimipramine—Ill-defined disorder—Dactinomycin—sarcoma	0.00158	0.00436	CcSEcCtD
Trimipramine—Agitation—Thiotepa—sarcoma	0.00157	0.00435	CcSEcCtD
Trimipramine—Acute coronary syndrome—Etoposide—sarcoma	0.00155	0.00429	CcSEcCtD
Trimipramine—ADRA2A—seminal vesicle—sarcoma	0.00155	0.00934	CbGeAlD
Trimipramine—Neuropathy peripheral—Etoposide—sarcoma	0.00154	0.00427	CcSEcCtD
Trimipramine—Myocardial infarction—Etoposide—sarcoma	0.00154	0.00427	CcSEcCtD
Trimipramine—Alopecia—Vincristine—sarcoma	0.00154	0.00426	CcSEcCtD
Trimipramine—Stomatitis—Etoposide—sarcoma	0.00153	0.00424	CcSEcCtD
Trimipramine—Jaundice—Etoposide—sarcoma	0.00153	0.00424	CcSEcCtD
Trimipramine—Malaise—Dactinomycin—sarcoma	0.00153	0.00424	CcSEcCtD
Trimipramine—CYP2C9—hematopoietic system—sarcoma	0.00152	0.00916	CbGeAlD
Trimipramine—Arrhythmia—Mitoxantrone—sarcoma	0.00152	0.0042	CcSEcCtD
Trimipramine—Atrioventricular block—Doxorubicin—sarcoma	0.0015	0.00416	CcSEcCtD
Trimipramine—Alopecia—Mitoxantrone—sarcoma	0.0015	0.00415	CcSEcCtD
Trimipramine—HRH1—hematopoietic system—sarcoma	0.0015	0.00903	CbGeAlD
Trimipramine—Coordination abnormal—Doxorubicin—sarcoma	0.00148	0.00411	CcSEcCtD
Trimipramine—Convulsion—Thiotepa—sarcoma	0.00148	0.0041	CcSEcCtD
Trimipramine—Hypertension—Thiotepa—sarcoma	0.00148	0.00409	CcSEcCtD
Trimipramine—ADRA2A—hematopoietic system—sarcoma	0.00147	0.00887	CbGeAlD
Trimipramine—Agranulocytosis—Etoposide—sarcoma	0.00147	0.00406	CcSEcCtD
Trimipramine—Anxiety—Thiotepa—sarcoma	0.00145	0.00402	CcSEcCtD
Trimipramine—Dysgeusia—Mitoxantrone—sarcoma	0.00145	0.004	CcSEcCtD
Trimipramine—HRH1—connective tissue—sarcoma	0.00144	0.0087	CbGeAlD
Trimipramine—Discomfort—Dactinomycin—sarcoma	0.00143	0.00395	CcSEcCtD
Trimipramine—ADRA2A—connective tissue—sarcoma	0.00142	0.00854	CbGeAlD
Trimipramine—SLC6A3—testis—sarcoma	0.00142	0.00853	CbGeAlD
Trimipramine—Confusional state—Thiotepa—sarcoma	0.00141	0.0039	CcSEcCtD
Trimipramine—Hypoaesthesia—Etoposide—sarcoma	0.0014	0.00389	CcSEcCtD
Trimipramine—HTR2A—embryo—sarcoma	0.0014	0.00845	CbGeAlD
Trimipramine—Agitation—Vincristine—sarcoma	0.00139	0.00386	CcSEcCtD
Trimipramine—Vision blurred—Mitoxantrone—sarcoma	0.00139	0.00385	CcSEcCtD
Trimipramine—Oedema—Dactinomycin—sarcoma	0.00139	0.00384	CcSEcCtD
Trimipramine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00137	0.00379	CcSEcCtD
Trimipramine—Thrombocytopenia—Thiotepa—sarcoma	0.00137	0.00378	CcSEcCtD
Trimipramine—ADRA1A—lymphoid tissue—sarcoma	0.00136	0.00822	CbGeAlD
Trimipramine—Tachycardia—Thiotepa—sarcoma	0.00136	0.00377	CcSEcCtD
Trimipramine—Thrombocytopenia—Dactinomycin—sarcoma	0.00136	0.00376	CcSEcCtD
Trimipramine—Malaise—Mitoxantrone—sarcoma	0.00133	0.00369	CcSEcCtD
Trimipramine—Anorexia—Thiotepa—sarcoma	0.00133	0.00368	CcSEcCtD
Trimipramine—Anorexia—Dactinomycin—sarcoma	0.00132	0.00366	CcSEcCtD
Trimipramine—HRH1—smooth muscle tissue—sarcoma	0.00132	0.00796	CbGeAlD
Trimipramine—Convulsion—Vincristine—sarcoma	0.00131	0.00364	CcSEcCtD
Trimipramine—Flushing—Etoposide—sarcoma	0.00131	0.00363	CcSEcCtD
Trimipramine—Hypertension—Vincristine—sarcoma	0.00131	0.00363	CcSEcCtD
Trimipramine—Convulsion—Mitoxantrone—sarcoma	0.00128	0.00354	CcSEcCtD
Trimipramine—Vascular purpura—Epirubicin—sarcoma	0.00128	0.00354	CcSEcCtD
Trimipramine—Hypertension—Mitoxantrone—sarcoma	0.00128	0.00353	CcSEcCtD
Trimipramine—Paraesthesia—Thiotepa—sarcoma	0.00125	0.00347	CcSEcCtD
Trimipramine—Anxiety—Mitoxantrone—sarcoma	0.00125	0.00347	CcSEcCtD
Trimipramine—HTR2A—hematopoietic system—sarcoma	0.00125	0.00755	CbGeAlD
Trimipramine—Alopecia—Etoposide—sarcoma	0.00125	0.00345	CcSEcCtD
Trimipramine—Discomfort—Mitoxantrone—sarcoma	0.00124	0.00344	CcSEcCtD
Trimipramine—Somnolence—Thiotepa—sarcoma	0.00124	0.00344	CcSEcCtD
Trimipramine—Oedema—Vincristine—sarcoma	0.00124	0.00343	CcSEcCtD
Trimipramine—Dyspepsia—Thiotepa—sarcoma	0.00123	0.0034	CcSEcCtD
Trimipramine—Confusional state—Mitoxantrone—sarcoma	0.00122	0.00337	CcSEcCtD
Trimipramine—Decreased appetite—Thiotepa—sarcoma	0.00121	0.00336	CcSEcCtD
Trimipramine—Thrombocytopenia—Vincristine—sarcoma	0.00121	0.00336	CcSEcCtD
Trimipramine—Oedema—Mitoxantrone—sarcoma	0.00121	0.00334	CcSEcCtD
Trimipramine—HTR2A—connective tissue—sarcoma	0.00121	0.00726	CbGeAlD
Trimipramine—Decreased appetite—Dactinomycin—sarcoma	0.0012	0.00333	CcSEcCtD
Trimipramine—Fatigue—Thiotepa—sarcoma	0.0012	0.00333	CcSEcCtD
Trimipramine—Dysgeusia—Etoposide—sarcoma	0.0012	0.00333	CcSEcCtD
Trimipramine—Fatigue—Dactinomycin—sarcoma	0.00119	0.00331	CcSEcCtD
Trimipramine—Constipation—Thiotepa—sarcoma	0.00119	0.0033	CcSEcCtD
Trimipramine—Purpura—Epirubicin—sarcoma	0.00119	0.00328	CcSEcCtD
Trimipramine—Vascular purpura—Doxorubicin—sarcoma	0.00118	0.00327	CcSEcCtD
Trimipramine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00118	0.00327	CcSEcCtD
Trimipramine—Anorexia—Vincristine—sarcoma	0.00118	0.00327	CcSEcCtD
Trimipramine—Tachycardia—Mitoxantrone—sarcoma	0.00118	0.00326	CcSEcCtD
Trimipramine—Cerebrovascular accident—Epirubicin—sarcoma	0.00117	0.00323	CcSEcCtD
Trimipramine—CYP3A4—hematopoietic system—sarcoma	0.00116	0.00699	CbGeAlD
Trimipramine—Hypotension—Vincristine—sarcoma	0.00116	0.0032	CcSEcCtD
Trimipramine—Feeling abnormal—Thiotepa—sarcoma	0.00115	0.00318	CcSEcCtD
Trimipramine—Anorexia—Mitoxantrone—sarcoma	0.00115	0.00318	CcSEcCtD
Trimipramine—Feeling abnormal—Dactinomycin—sarcoma	0.00114	0.00316	CcSEcCtD
Trimipramine—SLC6A2—testis—sarcoma	0.00114	0.00688	CbGeAlD
Trimipramine—CYP2D6—hematopoietic system—sarcoma	0.00114	0.00687	CbGeAlD
Trimipramine—Ill-defined disorder—Etoposide—sarcoma	0.00114	0.00316	CcSEcCtD
Trimipramine—Hypotension—Mitoxantrone—sarcoma	0.00113	0.00312	CcSEcCtD
Trimipramine—Insomnia—Vincristine—sarcoma	0.00112	0.0031	CcSEcCtD
Trimipramine—ADRA2A—cardiac atrium—sarcoma	0.00112	0.00674	CbGeAlD
Trimipramine—ADRA2A—uterus—sarcoma	0.00111	0.0067	CbGeAlD
Trimipramine—Paraesthesia—Vincristine—sarcoma	0.00111	0.00308	CcSEcCtD
Trimipramine—Urticaria—Thiotepa—sarcoma	0.00111	0.00307	CcSEcCtD
Trimipramine—Malaise—Etoposide—sarcoma	0.00111	0.00307	CcSEcCtD
Trimipramine—Abdominal pain—Thiotepa—sarcoma	0.0011	0.00306	CcSEcCtD
Trimipramine—Body temperature increased—Thiotepa—sarcoma	0.0011	0.00306	CcSEcCtD
Trimipramine—HTR2A—smooth muscle tissue—sarcoma	0.0011	0.00665	CbGeAlD
Trimipramine—Purpura—Doxorubicin—sarcoma	0.0011	0.00304	CcSEcCtD
Trimipramine—Body temperature increased—Dactinomycin—sarcoma	0.0011	0.00303	CcSEcCtD
Trimipramine—Abdominal pain—Dactinomycin—sarcoma	0.0011	0.00303	CcSEcCtD
Trimipramine—Paraesthesia—Mitoxantrone—sarcoma	0.00108	0.003	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00108	0.00299	CcSEcCtD
Trimipramine—Decreased appetite—Vincristine—sarcoma	0.00108	0.00298	CcSEcCtD
Trimipramine—Ataxia—Epirubicin—sarcoma	0.00108	0.00298	CcSEcCtD
Trimipramine—Somnolence—Mitoxantrone—sarcoma	0.00107	0.00297	CcSEcCtD
Trimipramine—Fatigue—Vincristine—sarcoma	0.00107	0.00295	CcSEcCtD
Trimipramine—Convulsion—Etoposide—sarcoma	0.00106	0.00295	CcSEcCtD
Trimipramine—Dyspepsia—Mitoxantrone—sarcoma	0.00106	0.00294	CcSEcCtD
Trimipramine—Hypertension—Etoposide—sarcoma	0.00106	0.00294	CcSEcCtD
Trimipramine—Constipation—Vincristine—sarcoma	0.00106	0.00293	CcSEcCtD
Trimipramine—Decreased appetite—Mitoxantrone—sarcoma	0.00105	0.0029	CcSEcCtD
Trimipramine—DRD2—testis—sarcoma	0.00104	0.00627	CbGeAlD
Trimipramine—Fatigue—Mitoxantrone—sarcoma	0.00104	0.00288	CcSEcCtD
Trimipramine—Discomfort—Etoposide—sarcoma	0.00103	0.00286	CcSEcCtD
Trimipramine—Constipation—Mitoxantrone—sarcoma	0.00103	0.00285	CcSEcCtD
Trimipramine—CYP2C19—liver—sarcoma	0.00102	0.00612	CbGeAlD
Trimipramine—Confusional state—Etoposide—sarcoma	0.00101	0.0028	CcSEcCtD
Trimipramine—ADRA1A—liver—sarcoma	0.001	0.00605	CbGeAlD
Trimipramine—Asthenia—Thiotepa—sarcoma	0.001	0.00277	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—sarcoma	0.000995	0.00275	CcSEcCtD
Trimipramine—Asthenia—Dactinomycin—sarcoma	0.000994	0.00275	CcSEcCtD
Trimipramine—Feeling abnormal—Mitoxantrone—sarcoma	0.000994	0.00275	CcSEcCtD
Trimipramine—HRH1—tendon—sarcoma	0.000992	0.00598	CbGeAlD
Trimipramine—Pruritus—Thiotepa—sarcoma	0.000988	0.00273	CcSEcCtD
Trimipramine—Thrombocytopenia—Etoposide—sarcoma	0.000982	0.00272	CcSEcCtD
Trimipramine—Tachycardia—Etoposide—sarcoma	0.000979	0.00271	CcSEcCtD
Trimipramine—Eosinophilia—Epirubicin—sarcoma	0.000979	0.00271	CcSEcCtD
Trimipramine—Abdominal pain—Vincristine—sarcoma	0.000979	0.00271	CcSEcCtD
Trimipramine—Body temperature increased—Vincristine—sarcoma	0.000979	0.00271	CcSEcCtD
Trimipramine—ADRA2A—tendon—sarcoma	0.000975	0.00587	CbGeAlD
Trimipramine—Urticaria—Mitoxantrone—sarcoma	0.000958	0.00265	CcSEcCtD
Trimipramine—Anorexia—Etoposide—sarcoma	0.000956	0.00265	CcSEcCtD
Trimipramine—ABCB1—myometrium—sarcoma	0.000956	0.00576	CbGeAlD
Trimipramine—Diarrhoea—Thiotepa—sarcoma	0.000955	0.00264	CcSEcCtD
Trimipramine—Body temperature increased—Mitoxantrone—sarcoma	0.000953	0.00264	CcSEcCtD
Trimipramine—Abdominal pain—Mitoxantrone—sarcoma	0.000953	0.00264	CcSEcCtD
Trimipramine—Diarrhoea—Dactinomycin—sarcoma	0.000948	0.00262	CcSEcCtD
Trimipramine—Pancytopenia—Epirubicin—sarcoma	0.000939	0.0026	CcSEcCtD
Trimipramine—Hypotension—Etoposide—sarcoma	0.000937	0.00259	CcSEcCtD
Trimipramine—Dizziness—Thiotepa—sarcoma	0.000923	0.00256	CcSEcCtD
Trimipramine—ABCB1—embryo—sarcoma	0.000919	0.00554	CbGeAlD
Trimipramine—Pollakiuria—Epirubicin—sarcoma	0.000913	0.00253	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—sarcoma	0.000906	0.00251	CcSEcCtD
Trimipramine—Paraesthesia—Etoposide—sarcoma	0.000901	0.00249	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—sarcoma	0.0009	0.00249	CcSEcCtD
Trimipramine—Somnolence—Etoposide—sarcoma	0.000892	0.00247	CcSEcCtD
Trimipramine—Asthenia—Vincristine—sarcoma	0.000888	0.00246	CcSEcCtD
Trimipramine—Vomiting—Thiotepa—sarcoma	0.000888	0.00246	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—sarcoma	0.000882	0.00244	CcSEcCtD
Trimipramine—Vomiting—Dactinomycin—sarcoma	0.000881	0.00244	CcSEcCtD
Trimipramine—Rash—Thiotepa—sarcoma	0.00088	0.00244	CcSEcCtD
Trimipramine—Dermatitis—Thiotepa—sarcoma	0.00088	0.00243	CcSEcCtD
Trimipramine—Headache—Thiotepa—sarcoma	0.000875	0.00242	CcSEcCtD
Trimipramine—Rash—Dactinomycin—sarcoma	0.000874	0.00242	CcSEcCtD
Trimipramine—Decreased appetite—Etoposide—sarcoma	0.000872	0.00241	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—sarcoma	0.000869	0.0024	CcSEcCtD
Trimipramine—Asthenia—Mitoxantrone—sarcoma	0.000865	0.00239	CcSEcCtD
Trimipramine—Fatigue—Etoposide—sarcoma	0.000865	0.00239	CcSEcCtD
Trimipramine—Neuropathy peripheral—Epirubicin—sarcoma	0.000864	0.00239	CcSEcCtD
Trimipramine—ABCB1—seminal vesicle—sarcoma	0.000863	0.0052	CbGeAlD
Trimipramine—Jaundice—Epirubicin—sarcoma	0.000859	0.00238	CcSEcCtD
Trimipramine—Stomatitis—Epirubicin—sarcoma	0.000859	0.00238	CcSEcCtD
Trimipramine—Constipation—Etoposide—sarcoma	0.000858	0.00237	CcSEcCtD
Trimipramine—Diarrhoea—Vincristine—sarcoma	0.000847	0.00234	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—sarcoma	0.000845	0.00234	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—sarcoma	0.000833	0.0023	CcSEcCtD
Trimipramine—Nausea—Thiotepa—sarcoma	0.000829	0.0023	CcSEcCtD
Trimipramine—HTR2A—tendon—sarcoma	0.000829	0.00499	CbGeAlD
Trimipramine—SLC6A2—lymph node—sarcoma	0.000828	0.00499	CbGeAlD
Trimipramine—Feeling abnormal—Etoposide—sarcoma	0.000827	0.00229	CcSEcCtD
Trimipramine—Diarrhoea—Mitoxantrone—sarcoma	0.000825	0.00228	CcSEcCtD
Trimipramine—Nausea—Dactinomycin—sarcoma	0.000823	0.00228	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—sarcoma	0.000823	0.00228	CcSEcCtD
Trimipramine—HRH1—testis—sarcoma	0.000822	0.00495	CbGeAlD
Trimipramine—ABCB1—hematopoietic system—sarcoma	0.000821	0.00494	CbGeAlD
Trimipramine—Dizziness—Vincristine—sarcoma	0.000819	0.00227	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—sarcoma	0.000816	0.00226	CcSEcCtD
Trimipramine—ADRA2A—testis—sarcoma	0.000807	0.00486	CbGeAlD
Trimipramine—Neuropathy peripheral—Doxorubicin—sarcoma	0.0008	0.00221	CcSEcCtD
Trimipramine—Urticaria—Etoposide—sarcoma	0.000797	0.00221	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—sarcoma	0.000795	0.0022	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—sarcoma	0.000795	0.0022	CcSEcCtD
Trimipramine—Abdominal pain—Etoposide—sarcoma	0.000793	0.00219	CcSEcCtD
Trimipramine—Body temperature increased—Etoposide—sarcoma	0.000793	0.00219	CcSEcCtD
Trimipramine—CYP2C9—liver—sarcoma	0.000788	0.00475	CbGeAlD
Trimipramine—Hypoaesthesia—Epirubicin—sarcoma	0.000787	0.00218	CcSEcCtD
Trimipramine—Vomiting—Vincristine—sarcoma	0.000787	0.00218	CcSEcCtD
Trimipramine—Rash—Vincristine—sarcoma	0.000781	0.00216	CcSEcCtD
Trimipramine—Dermatitis—Vincristine—sarcoma	0.00078	0.00216	CcSEcCtD
Trimipramine—Headache—Vincristine—sarcoma	0.000776	0.00215	CcSEcCtD
Trimipramine—Vomiting—Mitoxantrone—sarcoma	0.000767	0.00212	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—sarcoma	0.000761	0.00211	CcSEcCtD
Trimipramine—Rash—Mitoxantrone—sarcoma	0.00076	0.0021	CcSEcCtD
Trimipramine—Dermatitis—Mitoxantrone—sarcoma	0.00076	0.0021	CcSEcCtD
Trimipramine—Headache—Mitoxantrone—sarcoma	0.000755	0.00209	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—sarcoma	0.000738	0.00204	CcSEcCtD
Trimipramine—Nausea—Vincristine—sarcoma	0.000735	0.00204	CcSEcCtD
Trimipramine—Flushing—Epirubicin—sarcoma	0.000734	0.00203	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—sarcoma	0.000729	0.00202	CcSEcCtD
Trimipramine—Asthenia—Etoposide—sarcoma	0.00072	0.00199	CcSEcCtD
Trimipramine—Nausea—Mitoxantrone—sarcoma	0.000716	0.00198	CcSEcCtD
Trimipramine—Pruritus—Etoposide—sarcoma	0.00071	0.00196	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—sarcoma	0.000707	0.00196	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—sarcoma	0.000699	0.00194	CcSEcCtD
Trimipramine—Diarrhoea—Etoposide—sarcoma	0.000686	0.0019	CcSEcCtD
Trimipramine—HTR2A—testis—sarcoma	0.000686	0.00413	CbGeAlD
Trimipramine—Tinnitus—Doxorubicin—sarcoma	0.000683	0.00189	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—sarcoma	0.00068	0.00188	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—sarcoma	0.000675	0.00187	CcSEcCtD
Trimipramine—Dizziness—Etoposide—sarcoma	0.000663	0.00184	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—sarcoma	0.000654	0.00181	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—sarcoma	0.000649	0.0018	CcSEcCtD
Trimipramine—HTR2A—liver—sarcoma	0.000649	0.00391	CbGeAlD
Trimipramine—Alopecia—Doxorubicin—sarcoma	0.000647	0.00179	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—sarcoma	0.000639	0.00177	CcSEcCtD
Trimipramine—Vomiting—Etoposide—sarcoma	0.000638	0.00177	CcSEcCtD
Trimipramine—Agitation—Epirubicin—sarcoma	0.000633	0.00175	CcSEcCtD
Trimipramine—Rash—Etoposide—sarcoma	0.000632	0.00175	CcSEcCtD
Trimipramine—Dermatitis—Etoposide—sarcoma	0.000632	0.00175	CcSEcCtD
Trimipramine—Headache—Etoposide—sarcoma	0.000628	0.00174	CcSEcCtD
Trimipramine—CYP2D6—testis—sarcoma	0.000625	0.00377	CbGeAlD
Trimipramine—Dysgeusia—Doxorubicin—sarcoma	0.000624	0.00173	CcSEcCtD
Trimipramine—Malaise—Epirubicin—sarcoma	0.000621	0.00172	CcSEcCtD
Trimipramine—ABCB1—uterus—sarcoma	0.00062	0.00373	CbGeAlD
Trimipramine—Palpitations—Epirubicin—sarcoma	0.000609	0.00168	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—sarcoma	0.000601	0.00166	CcSEcCtD
Trimipramine—CYP3A4—liver—sarcoma	0.000601	0.00362	CbGeAlD
Trimipramine—Convulsion—Epirubicin—sarcoma	0.000597	0.00165	CcSEcCtD
Trimipramine—Nausea—Etoposide—sarcoma	0.000596	0.00165	CcSEcCtD
Trimipramine—HRH1—lymph node—sarcoma	0.000596	0.00359	CbGeAlD
Trimipramine—Hypertension—Epirubicin—sarcoma	0.000595	0.00165	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—sarcoma	0.000591	0.00164	CcSEcCtD
Trimipramine—CYP2D6—liver—sarcoma	0.000591	0.00356	CbGeAlD
Trimipramine—Agitation—Doxorubicin—sarcoma	0.000586	0.00162	CcSEcCtD
Trimipramine—ADRA2A—lymph node—sarcoma	0.000585	0.00352	CbGeAlD
Trimipramine—Anxiety—Epirubicin—sarcoma	0.000584	0.00162	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—sarcoma	0.000579	0.0016	CcSEcCtD
Trimipramine—ABCB1—lymphoid tissue—sarcoma	0.000578	0.00348	CbGeAlD
Trimipramine—Malaise—Doxorubicin—sarcoma	0.000575	0.00159	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—sarcoma	0.000574	0.00159	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—sarcoma	0.000567	0.00157	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—sarcoma	0.000563	0.00156	CcSEcCtD
Trimipramine—Oedema—Epirubicin—sarcoma	0.000562	0.00156	CcSEcCtD
Trimipramine—Convulsion—Doxorubicin—sarcoma	0.000552	0.00153	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—sarcoma	0.00055	0.00152	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—sarcoma	0.00055	0.00152	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—sarcoma	0.000549	0.00152	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—sarcoma	0.000541	0.0015	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—sarcoma	0.000536	0.00148	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—sarcoma	0.000536	0.00148	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—sarcoma	0.000531	0.00147	CcSEcCtD
Trimipramine—ABCB1—bone marrow—sarcoma	0.000526	0.00317	CbGeAlD
Trimipramine—Hypotension—Epirubicin—sarcoma	0.000525	0.00145	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—sarcoma	0.000525	0.00145	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—sarcoma	0.00052	0.00144	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—sarcoma	0.000509	0.00141	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—sarcoma	0.000509	0.00141	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—sarcoma	0.000508	0.00141	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—sarcoma	0.000505	0.0014	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—sarcoma	0.0005	0.00138	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—sarcoma	0.000496	0.00137	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—sarcoma	0.000495	0.00137	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—sarcoma	0.000489	0.00135	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—sarcoma	0.000486	0.00135	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—sarcoma	0.000485	0.00134	CcSEcCtD
Trimipramine—Constipation—Epirubicin—sarcoma	0.000481	0.00133	CcSEcCtD
Trimipramine—Insomnia—Doxorubicin—sarcoma	0.000471	0.0013	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—sarcoma	0.000467	0.00129	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—sarcoma	0.000463	0.00128	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—sarcoma	0.000462	0.00128	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—sarcoma	0.000458	0.00127	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—sarcoma	0.000452	0.00125	CcSEcCtD
Trimipramine—ABCB1—testis—sarcoma	0.00045	0.00271	CbGeAlD
Trimipramine—Fatigue—Doxorubicin—sarcoma	0.000449	0.00124	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—sarcoma	0.000447	0.00124	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—sarcoma	0.000445	0.00123	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—sarcoma	0.000444	0.00123	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—sarcoma	0.000444	0.00123	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—sarcoma	0.000429	0.00119	CcSEcCtD
Trimipramine—ABCB1—liver—sarcoma	0.000425	0.00256	CbGeAlD
Trimipramine—Urticaria—Doxorubicin—sarcoma	0.000413	0.00114	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—sarcoma	0.000411	0.00114	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—sarcoma	0.000411	0.00114	CcSEcCtD
Trimipramine—Asthenia—Epirubicin—sarcoma	0.000403	0.00112	CcSEcCtD
Trimipramine—Pruritus—Epirubicin—sarcoma	0.000398	0.0011	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—sarcoma	0.000385	0.00106	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—sarcoma	0.000373	0.00103	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—sarcoma	0.000372	0.00103	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—sarcoma	0.000368	0.00102	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—sarcoma	0.000357	0.000989	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—sarcoma	0.000356	0.000985	CcSEcCtD
Trimipramine—Rash—Epirubicin—sarcoma	0.000354	0.000981	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—sarcoma	0.000354	0.00098	CcSEcCtD
Trimipramine—Headache—Epirubicin—sarcoma	0.000352	0.000975	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—sarcoma	0.000344	0.000952	CcSEcCtD
Trimipramine—Nausea—Epirubicin—sarcoma	0.000334	0.000924	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—sarcoma	0.000331	0.000915	CcSEcCtD
Trimipramine—Rash—Doxorubicin—sarcoma	0.000328	0.000908	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—sarcoma	0.000328	0.000907	CcSEcCtD
Trimipramine—ABCB1—lymph node—sarcoma	0.000326	0.00196	CbGeAlD
Trimipramine—Headache—Doxorubicin—sarcoma	0.000326	0.000902	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—sarcoma	0.000309	0.000855	CcSEcCtD
